PharmaShots | Incisive News in 3 Shots

Subscribe Now

Lenacapavir

Gilead Reports EMA's Validation of MAA for Lenacapavir to Treat HIV-1 in People with Limited Therapy Options

Gilead Reports EMA's Validation of MAA for Lenacapavir to Treat HIV-1 in People with Limited Therapy Options

August 20, 2021

Gilead Reports Submission of NDA to the US FDA for Lenacapavir to Treat HIV-1 in People with Limited Therapy Options

Gilead Reports Submission of NDA to the US FDA for Lenacapavir to Treat HIV-1 in People with Limited Therapy Options

June 29, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us